All Pharmaceutical Microbiology articles – Page 17
-
NewsAI can speed antibody design to thwart novel viruses: study
Artificial intelligence (AI) and “protein language” models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according to a multi-institutional study
-
NewsNew study finds targets for a new tuberculosis vaccine
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.
-
NewsBreathing new life Into TB treatment with inhalable nanomedicine
Scientists are developing an inhalable nanosystem to transport TB medicines directly into the lungs, the very place where the bacterium that causes TB hides and thrives. The nanocarrier can hold all four standard TB drugs in a single formulation and release them precisely at the infection site.
-
NewsHorizon Awards 2025: Dr Manu De Rycker named as winner of WH Pierce Prize
Dr Manu De Rycker, a Principal Investigator at the University of Dundee, has been named as the newest winner of the WH Pierce Global Impact in Microbiology Prize.
-
NewsNew compound cuts off protein supply to parasites
There is an urgent need for new active ingredients that are capable of circumventing existing resistances in malaria. Researchers have now identified a new drug candidate, ’Substance 31’, which could enable the development of a new malaria drug.
-
NewsBay Area Lyme Foundation opens applications for 2026 Emerging Leader Awards and research grants
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has announced its call for applicants from academia and the private sector for the 2026 Emerging Leader Awards (ELA).
-
NewsBacteria deliver synthetic, animal-free way to grow organoids in 3D
Researchers have developed a completely animal-free gel to grow organoids, miniature three dimensional versions of organs. By combining the bacterial protein invasin with a synthetic gel, they created an environment in which organoids can grow and expand long-term.
-
NewsNew hope for cats with eye infections: Study finds common cold sore cream safe and effective for feline use
A common human cold sore cream may soon help cats with painful eye infections: researchers found that 1% penciclovir cream (Fenlips®), when applied to cats’ eyes, was safe, well-tolerated, and maintained antiviral levels for over eight hours.
-
NewsHuman Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies
Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy.
-
NewsIUCN members choose science and ethics in landmark vote on synthetic biology
The Wildlife Conservation Society (WCS) has hailed the adoption of Motion 87, supporting the responsible, evidence-based use of synthetic biology, at the IUCN World Conservation Congress in Abu Dhabi as a historic milestone for global conservation policy.
-
NewsBreakthrough in coronavirus fight: scientists develop powerful bispecific inhibitor to combat a wide range of coronaviruses
Researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid.
-
NewsResearchers discover method to combat antibiotic treatment failure
Researchers explored ways to alter our own immune cells to help antibiotics work more effectively. They identified a small molecule that alters the body’s immune cells, forcing them to ’wake up’ dormant bacteria and make them more vulnerable to antibiotic treatment.
-
NewsCompound from Antarctic microorganism can be used to produce food, cosmetics, and medicine
A bioactive compound produced by the microorganism Bacillus licheniformis, found on Deception Island in Antarctica, has properties that qualify it for use in producing food, cosmetics, pharmaceuticals, and biodegradable materials.
-
NewsCould targeted steroid use offer a universal complimentary treatment to fight TB?
Newly published research provides evidence that treating patients with steroids may enhance the function of their macrophages to kill the mycobacteria, while diminishing pathways of inflammatory damage.
-
News‘Cocktails’ of common pharmaceuticals in our waterways may promote antibiotic resistance
New research has shown, for the first time, how mixtures of commonly used medications which end up in our waterways and natural environments might increase the development of antibiotic resistant bacteria.
-
NewsStructural diversity of pyripyropenes via biosynthetic gene cluster design and heterologous expression in Aspergillus nidulans
Researchers have designed a reconstituted biosynthetic gene cluster (BGC) for producing structurally diversified deacetylated pyripyropenes, using the native pyripyropene A BGC from the wild-type strain Aspergillus fumigatus Af 293 as a template.
-
NewsTraditional Chinese medicine combined with peginterferon α-2b in chronic hepatitis B
A new study demonstrates that adjunctive Traditional Chinese Medicine significantly enhances the antiviral efficacy of peginterferon α-2b in HBeAg-positive chronic hepatitis B while concurrently mitigating treatment-limiting myelosuppression.
-
NewsScientists reveal role of paeoniflorin in mediating microbiota-gut-brain axis
Paeoniflorin treatment significantly reduced depression-like behaviours in stressed rats, while gut microbiota analysis revealed that the treatment corrected imbalances in key metabolites associated with brain function, a study shows.
-
NewsSlime mold metabolites are a promising, eco-friendly repellent of root-knot nematodes
A team of researchers has discovered 14 compounds secreted by slime molds that repel root-knot nematodes (RKNs) - worm-like parasites of the genus Meloidogyne - and could be the source of new, non-toxic anti-RKN pesticides.
-
NewsEngineered bacterial therapy activates immune response in cancer preclinical studies
Researchers have developed a new bacterial immunotherapy that delivers immune-activating proteins directly to solid tumors, which can often suppress the immune system. ACTM-838 targets phagocytic immune cells within the tumor microenvironment.